Delivery Order SPE2DB22D2211-SPE2DB25FRTHH

Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,243.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty medication used in various medical treatments. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $34,831.45 and runs through March 4, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order with a firm fixed price of $17,489.40 and a completion date of December 23, 2024, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LUPRON DEPOT 11.25 MG 3MO KITS. The firm-fixed-price delivery order has a ceiling value of $2,111.16 and an ultimate completion date of August 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the supply of 4567410518 LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product, with a ceiling value of $8,631.36 and a completion date of February 28, 2025. This contract does not...
This federal contract award, valued at $20,767.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for LUPRON DEPOT 11.25 MG 3MO KITS, a medication used in various medical treatments. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,821.91 firm-fixed-price delivery order is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty medication. The contract has an ultimate completion date of August 10, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,721.26 delivery order is for the provision of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty medication. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, for a total ceiling value of $4,702.61. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 13, 2024....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,748.89 firm fixed-price delivery order is for the procurement of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty medication. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRTHH
    Delivery Order

The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LUPRON DEPOT 22.5 MG 3MO KITS. The contract has a ceiling value of $11,393.31 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/13/25, 10:02 AM